Comparative study of hormonal dynamics in pregnant and nonpregnant cycles during pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women

• Published in: Fertility and sterility Vol. 60; no. 2; pp. 254 - 261
• Main Authors: Nakamura, Yukio, Yoshimura, Yasunori, Oda, Takahisa, Shiokawa, Shigetatsu, Yoshinaga, Akari, Akiba, Masao
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.08.1993; Elsevier Science
• Subjects: Adult; Anovulation - blood; Anovulation - drug therapy; Biological and medical sciences; Birth control; Female; Gonadal Steroid Hormones - blood; Gynecology. Andrology. Obstetrics; hMG; Humans; Infertility, Female - blood; Infertility, Female - drug therapy; Injections, Subcutaneous; Medical sciences; Menotropins - administration & dosage; Menotropins - therapeutic use; P:E2; Pregnancy - blood; Pulsatile administration; Pulsatile Flow; Sterility. Assisted procreation; P; P:E2; hMG; Pulsatile administration; E2; Human; Menstruation disorders; Anovulation; HMG; Prognosis; Estrogen; Administration schedule; Female sterility; Gonadotropin; Glycoprotein hormone; Estradiol; Ovarian hormone; Pulsatile; Subcutaneous administration; Hormonal investigation; Progesterone; Therapeutic protocol; Sex steroid hormone
• ISSN: 0015-0282; 1556-5653
• DOI: 10.1016/S0015-0282(16)56093-2

To assess the clinical relevance of daily hormonal changes for achieving a successful pregnancy in anovulatory infertile women. A comparative study of hormonal dynamics in pregnant and nonpregnant cycles during the pulsatile subcutaneous administration of hMG. Subjects received subcutaneous injection of either 9.375 IU or 14.0625 IU of hMG diluted in 50-μL physiological saline (total daily dose, 150 or 225 IU) at 90-minute intervals by means of a portable peristaltic pump. Kyorin University Hospital and Ichikawa General Hospital. We analyzed 18 pregnant and 42 nonpregnant cycles in 17 patients with secondary hypothalamic/pituitary amenorrhea who conceived after receiving pulsatile hMG treatment. Another 14 women with normal spontaneous ovulation, including 14 pregnant and 15 nonpregnant cycles, served as controls. Serum concentrations of LH, FSH, E2, and P were measured, and the P:E2ratio was determined. Serum concentrations of LH and FSH did not differ significantly between the pregnant and nonpregnant cycles. Serum levels of P and E2were significantly higher during the hMG treatments than those of the spontaneous ovulatory cycles throughout the follicular and luteal phases. Up to the midluteal phase, the P and E2values in the nonpregnant cycles during the hMG treatments did not differ significantly from those in the pregnant cycles. The P:E2ratios were comparable between the pulsatile stimulatory cycles and the normal spontaneous ovulatory cycles. However, the P:E2ratio in the early and midluteal phases was significantly greater in the pregnant cycles than in the nonpregnant cycles. The P:E2 ratio in the early and midluteal phases is a more important indicator of hormonal function for implantation than the absolute levels of either P or E2.